The nuclear medicine equipment market size has grown strongly in recent years. It will grow from $2.81 billion in 2025 to $2.97 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to aging population growth, rising cancer prevalence, increased adoption of diagnostic imaging, expansion of hospital infrastructure, government funding for nuclear medicine.
The nuclear medicine equipment market size is expected to see strong growth in the next few years. It will grow to $3.67 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to growth in theranostics adoption, increasing precision medicine demand, technological advancements in hybrid imaging, rising cardiovascular disease burden, expansion of imaging centers in emerging markets. Major trends in the forecast period include advanced hybrid imaging systems, expansion of theranostics applications, increasing adoption of personalized nuclear diagnostics, growing focus on radiation dose optimization, rising demand for outpatient nuclear imaging services.
The increasing prevalence of cardiac ailments is increasingly supporting the expansion of the nuclear medicine equipment market going forward. Cardiac ailments, also referred to as cardiovascular diseases, include a wide range of conditions that affect the heart and blood vessels and can impair cardiac structure, function, or blood flow. The prevalence of these ailments is influenced by aging populations, lifestyle-related factors such as poor diet and limited physical activity, environmental exposures, and improved diagnostic technologies that enhance detection rates. Nuclear medicine equipment is widely used in cardiac care to deliver precise imaging and diagnostic data that support early detection, accurate assessment, and effective monitoring of heart conditions. For example, in January 2024, according to the British Heart Foundation, a UK-based cardiovascular research charity, approximately 7.6 million people in the UK were living with heart and circulatory diseases, accounting for about 27% of all deaths annually. As a result, the rising burden of cardiac ailments is reinforcing demand for nuclear medicine equipment.
Leading companies operating in the nuclear medicine equipment market are focused on developing advanced imaging products such as PET/CT scanners to deliver detailed functional and anatomical insights into metabolic processes. PET/CT scanners combine positron emission tomography and computed tomography to provide high-resolution diagnostic imaging in a single examination. For example, in June 2024, Siemens Healthineers, a Germany-based healthcare company, launched the Biograph Trinion PET/CT scanner. The system features a scalable axial field-of-view design, high-resolution LSO crystal detectors, ultrafast time-of-flight performance, and an air-cooled digital detector, enabling faster scans, lower radiation doses, and simplified installation while supporting future technological upgrades.
In November 2023, Mirion Technologies Inc., a US-based company specializing in radiation detection, measurement, and protection equipment, acquired ec2 Software Solutions for an undisclosed amount. With this acquisition, Mirion Technologies seeks to enhance its nuclear medicine and molecular imaging portfolio by integrating ec2’s advanced software solutions and expanding its ability to deliver comprehensive imaging and data management offerings. ec² Software Solutions is a US-based provider of nuclear medicine equipment.
Major companies operating in the nuclear medicine equipment market are Fujifilm Holdings Corporation, Koninklijke Philips N.V., General Electric Company, Shimadzu Corporation, Mallinckrodt Pharmaceuticals, Curium Pharma, Cardinal Health Inc., Canon Medical Systems Corporation, Digirad Corporation, TTG Imaging Solutions, Biodex Medical Systems Inc., Spectrum Dynamics Medical, Mediso Ltd., Cyclopharm Limited, Siemens Healthineers AG, Capintec Inc., Toshiba Medical Systems Corporation, Elysia-Raytest, DDD-Diagnostic A/S, MILabs B.V.
North America was the largest region in the nuclear medicine equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nuclear medicine equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have created cost pressures in the nuclear medicine equipment market by increasing prices of imported imaging components, radioisotope handling systems, and advanced detector technologies. These impacts have been most evident in high-end segments such as PET/CT and PET/MRI systems and in regions reliant on imports, including Asia-Pacific and parts of Latin America. Elevated costs have slowed procurement cycles for hospitals and imaging centers, while encouraging manufacturers to localize production and diversify supply chains. In some cases, tariffs have positively supported domestic manufacturing and regional partnerships, strengthening long-term supply resilience.
The nuclear medicine equipment market research report is one of a series of new reports that provides nuclear medicine equipment market statistics, including nuclear medicine equipment industry global market size, regional shares, competitors with a nuclear medicine equipment market share, detailed nuclear medicine equipment market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear medicine equipment industry. This nuclear medicine equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Nuclear medicine equipment includes devices that use radioactive materials to diagnose and treat disease, capturing internal images or delivering targeted radiation therapy for conditions such as cancer and heart disorders.
The primary products in the nuclear medicine equipment include single photon emission computed tomography, hybrid positron emission tomography, and planar scintigraphy systems. Single photon emission computed tomography is an imaging method that uses gamma radiation to produce detailed three-dimensional images of internal organs and tissues. These systems are applied in oncology, cardiology, neurology, and other medical fields and are used by end users such as hospitals, imaging centers, academic institutions, research organizations, and others.
The nuclear medicine equipment market consists of sales of gamma cameras, dose calibrators, radiation detectors and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The nuclear medicine equipment market size is expected to see strong growth in the next few years. It will grow to $3.67 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to growth in theranostics adoption, increasing precision medicine demand, technological advancements in hybrid imaging, rising cardiovascular disease burden, expansion of imaging centers in emerging markets. Major trends in the forecast period include advanced hybrid imaging systems, expansion of theranostics applications, increasing adoption of personalized nuclear diagnostics, growing focus on radiation dose optimization, rising demand for outpatient nuclear imaging services.
The increasing prevalence of cardiac ailments is increasingly supporting the expansion of the nuclear medicine equipment market going forward. Cardiac ailments, also referred to as cardiovascular diseases, include a wide range of conditions that affect the heart and blood vessels and can impair cardiac structure, function, or blood flow. The prevalence of these ailments is influenced by aging populations, lifestyle-related factors such as poor diet and limited physical activity, environmental exposures, and improved diagnostic technologies that enhance detection rates. Nuclear medicine equipment is widely used in cardiac care to deliver precise imaging and diagnostic data that support early detection, accurate assessment, and effective monitoring of heart conditions. For example, in January 2024, according to the British Heart Foundation, a UK-based cardiovascular research charity, approximately 7.6 million people in the UK were living with heart and circulatory diseases, accounting for about 27% of all deaths annually. As a result, the rising burden of cardiac ailments is reinforcing demand for nuclear medicine equipment.
Leading companies operating in the nuclear medicine equipment market are focused on developing advanced imaging products such as PET/CT scanners to deliver detailed functional and anatomical insights into metabolic processes. PET/CT scanners combine positron emission tomography and computed tomography to provide high-resolution diagnostic imaging in a single examination. For example, in June 2024, Siemens Healthineers, a Germany-based healthcare company, launched the Biograph Trinion PET/CT scanner. The system features a scalable axial field-of-view design, high-resolution LSO crystal detectors, ultrafast time-of-flight performance, and an air-cooled digital detector, enabling faster scans, lower radiation doses, and simplified installation while supporting future technological upgrades.
In November 2023, Mirion Technologies Inc., a US-based company specializing in radiation detection, measurement, and protection equipment, acquired ec2 Software Solutions for an undisclosed amount. With this acquisition, Mirion Technologies seeks to enhance its nuclear medicine and molecular imaging portfolio by integrating ec2’s advanced software solutions and expanding its ability to deliver comprehensive imaging and data management offerings. ec² Software Solutions is a US-based provider of nuclear medicine equipment.
Major companies operating in the nuclear medicine equipment market are Fujifilm Holdings Corporation, Koninklijke Philips N.V., General Electric Company, Shimadzu Corporation, Mallinckrodt Pharmaceuticals, Curium Pharma, Cardinal Health Inc., Canon Medical Systems Corporation, Digirad Corporation, TTG Imaging Solutions, Biodex Medical Systems Inc., Spectrum Dynamics Medical, Mediso Ltd., Cyclopharm Limited, Siemens Healthineers AG, Capintec Inc., Toshiba Medical Systems Corporation, Elysia-Raytest, DDD-Diagnostic A/S, MILabs B.V.
North America was the largest region in the nuclear medicine equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nuclear medicine equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have created cost pressures in the nuclear medicine equipment market by increasing prices of imported imaging components, radioisotope handling systems, and advanced detector technologies. These impacts have been most evident in high-end segments such as PET/CT and PET/MRI systems and in regions reliant on imports, including Asia-Pacific and parts of Latin America. Elevated costs have slowed procurement cycles for hospitals and imaging centers, while encouraging manufacturers to localize production and diversify supply chains. In some cases, tariffs have positively supported domestic manufacturing and regional partnerships, strengthening long-term supply resilience.
The nuclear medicine equipment market research report is one of a series of new reports that provides nuclear medicine equipment market statistics, including nuclear medicine equipment industry global market size, regional shares, competitors with a nuclear medicine equipment market share, detailed nuclear medicine equipment market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear medicine equipment industry. This nuclear medicine equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Nuclear medicine equipment includes devices that use radioactive materials to diagnose and treat disease, capturing internal images or delivering targeted radiation therapy for conditions such as cancer and heart disorders.
The primary products in the nuclear medicine equipment include single photon emission computed tomography, hybrid positron emission tomography, and planar scintigraphy systems. Single photon emission computed tomography is an imaging method that uses gamma radiation to produce detailed three-dimensional images of internal organs and tissues. These systems are applied in oncology, cardiology, neurology, and other medical fields and are used by end users such as hospitals, imaging centers, academic institutions, research organizations, and others.
The nuclear medicine equipment market consists of sales of gamma cameras, dose calibrators, radiation detectors and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Nuclear Medicine Equipment Market Characteristics
3. Nuclear Medicine Equipment Market Supply Chain Analysis
4. Global Nuclear Medicine Equipment Market Trends and Strategies
5. Nuclear Medicine Equipment Market Analysis of End Use Industries
7. Global Nuclear Medicine Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Nuclear Medicine Equipment Total Addressable Market (TAM) Analysis for the Market
9. Nuclear Medicine Equipment Market Segmentation
10. Nuclear Medicine Equipment Market Regional and Country Analysis
11. Asia-Pacific Nuclear Medicine Equipment Market
12. China Nuclear Medicine Equipment Market
13. India Nuclear Medicine Equipment Market
14. Japan Nuclear Medicine Equipment Market
15. Australia Nuclear Medicine Equipment Market
16. Indonesia Nuclear Medicine Equipment Market
17. South Korea Nuclear Medicine Equipment Market
18. Taiwan Nuclear Medicine Equipment Market
19. South East Asia Nuclear Medicine Equipment Market
20. Western Europe Nuclear Medicine Equipment Market
21. UK Nuclear Medicine Equipment Market
22. Germany Nuclear Medicine Equipment Market
23. France Nuclear Medicine Equipment Market
24. Italy Nuclear Medicine Equipment Market
25. Spain Nuclear Medicine Equipment Market
26. Eastern Europe Nuclear Medicine Equipment Market
27. Russia Nuclear Medicine Equipment Market
28. North America Nuclear Medicine Equipment Market
29. USA Nuclear Medicine Equipment Market
30. Canada Nuclear Medicine Equipment Market
31. South America Nuclear Medicine Equipment Market
32. Brazil Nuclear Medicine Equipment Market
33. Middle East Nuclear Medicine Equipment Market
34. Africa Nuclear Medicine Equipment Market
36. Nuclear Medicine Equipment Market Competitive Landscape and Company Profiles
37. Nuclear Medicine Equipment Market Other Major and Innovative Companies
40. Nuclear Medicine Equipment Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Nuclear Medicine Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses nuclear medicine equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for nuclear medicine equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nuclear medicine equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Single Photon Emission Computed Tomography; Hybrid Positron Emission Tomography; Planar Scintigraphy2) By Application: Oncology; Cardiology; Neurology; Other Applications
3) By End User: Hospitals; Imaging Centers; Academic And Research Institutes; Other End Users
Subsegments:
1) By Single Photon Emission Computed Tomography: Standalone SPECT Systems; Hybrid SPECT Or CT Systems2) By Hybrid Positron Emission Tomography: PET Or CT Systems; PET Or MRI Systems
3) By Planar Scintigraphy: Cardiac Imaging Systems; Bone Scintigraphy Systems; Thyroid Imaging Systems
Companies Mentioned: Fujifilm Holdings Corporation; Koninklijke Philips N.V.; General Electric Company; Shimadzu Corporation; Mallinckrodt Pharmaceuticals; Curium Pharma; Cardinal Health Inc.; Canon Medical Systems Corporation; Digirad Corporation; TTG Imaging Solutions; Biodex Medical Systems Inc.; Spectrum Dynamics Medical; Mediso Ltd.; Cyclopharm Limited; Siemens Healthineers AG; Capintec Inc.; Toshiba Medical Systems Corporation; Elysia-Raytest; DDD-Diagnostic A/S; MILabs B.V.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Nuclear Medicine Equipment market report include:- Fujifilm Holdings Corporation
- Koninklijke Philips N.V.
- General Electric Company
- Shimadzu Corporation
- Mallinckrodt Pharmaceuticals
- Curium Pharma
- Cardinal Health Inc.
- Canon Medical Systems Corporation
- Digirad Corporation
- TTG Imaging Solutions
- Biodex Medical Systems Inc.
- Spectrum Dynamics Medical
- Mediso Ltd.
- Cyclopharm Limited
- Siemens Healthineers AG
- Capintec Inc.
- Toshiba Medical Systems Corporation
- Elysia-Raytest
- DDD-Diagnostic A/S
- MILabs B.V.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.97 Billion |
| Forecasted Market Value ( USD | $ 3.67 Billion |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
